Neuromyotonia: autoimmune pathogenesis and response to immune modulating therapy.
BACKGROUND
Neuromyotonia (NMT) has been postulated to be an autoimmune channelopathy, probably by affecting voltage gated potassium channels (VGKC) leading to excitation and abnormal discharges [Sinha et al., Lancet 338 (1991) 75].


OBJECTIVE
To report three patients with NMT who had other associated immune-mediated conditions, i.e., myasthenia gravis, thymoma and various types of peripheral neuropathies. One patient had peripheral neuropathy and involvement of pre- and post-synaptic neuromuscular junction.


RESULTS
All three patients had evidence of polyneuropathy and neuromyotonic discharges on electrodiagnostic studies. Elevated acetylcholine receptor antibodies were noted in all patients and malignant thymoma was found in two patients with metastasis. All three patients showed moderate to marked response to plasma exchange.


CONCLUSIONS
These findings strongly suggest a humoral autoimmune pathogenesis of NMT, probably by K(+) channel involvement, affecting acetylcholine quantal release and postsynaptic membrane. Clinicians should be aware of this association of immune-mediated conditions in NMT patients and marked improvement with plasma exchange.
Hayat
G R
GR
Department of Neurology, Saint Louis University, 3635 Vista at Grand Blvd., 63110-0250, St. Louis, MO, USA. hayatg@slucare1.sluh.edu
Kulkantrakorn
K
K
Campbell
W W
WW
Giuliani
M J
MJ
D000328:Adult; D000368:Aged; D006801:Humans; D007167:Immunotherapy; D020386:Isaacs Syndrome / Q000276:immunology* / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications / Q000276:immunology / Q000628:therapy; D009431:Neural Conduction / Q000502:physiology; D010523:Peripheral Nervous System Diseases / Q000150:complications / Q000175:diagnosis / Q000276:immunology; D010956:Plasmapheresis / Q000706:statistics & numerical data; D015221:Potassium Channels / Q000378:metabolism; D011950:Receptors, Cholinergic / Q000276:immunology / Q000378:metabolism; D013945:Thymoma / Q000150:complications / Q000276:immunology / Q000628:therapy
D015221:Potassium Channels; D011950:Receptors, Cholinergic